Members |
targetComponentId |
mannitol 10 %, infusionsvätska, lösning, flaska |
Product containing only mannitol in parenteral dose form (medicinal product form) |
Mannitol 10g/100mL injection |
Mannitol 100 mg/mL solution for injection |
mannitol 10 g/100 ml, injektionsvätska, lösning, påse 1 000 ml |
Mannitol 100 mg/mL solution for injection |
mannitol 10 g/100 ml, injektionsvätska, lösning, påse 500 ml |
Mannitol 100 mg/mL solution for injection |
mannitol 20 %, infusionsvätska, lösning, påse 250 ml |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
mannitol 20 %, infusionsvätska, lösning, påse 500 ml |
Product containing precisely mannitol 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
mannitol 20 %, infusionsvätska, lösning, flaska |
Product containing only mannitol in parenteral dose form (medicinal product form) |
Manual insertion |
Insertion - action (qualifier value) |
Marburg virus |
Genus Marburgvirus (organism) |
Marburg virus disease |
Marburg virus disease |
Marginal zone lymphoma |
Marginal zone B-cell lymphoma |
marint kräftdjur, livsmedel |
Marine crustacean (substance) |
marint blötdjur, livsmedel |
Marine mollusk (substance) |
Marital maladjustment |
Maladjustment to married life |
marlexpatch |
Polypropylene mesh (physical object) |
maskulinitet hos flicka |
Gender identity finding |
frakturtyper enligt Mason |
Fracture configurations |
frakturtyp 1 enligt Mason |
Mason type I fracture (morphologic abnormality) |
frakturtyp 2 enligt Mason |
Mason type II fracture |
frakturtyp 3 enligt Mason |
Mason type III fracture (morphologic abnormality) |
massör |
Massage therapist (occupation) |
Masseur |
Massage therapist (occupation) |
Mast cell leukemia |
Mast cell leukemia |
maternell 15q11q13-deletion |
Angelman syndrome due to maternal monosomy 15q11q13 (disorder) |
Maternal drug abuse |
Drug misuse by mother |
maxatasspecifikt extrakt |
Product containing maxatase (medicinal product) |
McCune-Albright syndrome |
Polyostotic fibrous dysplasia of bone |
Measles with other specified complications |
Measles with complication |
antikroppsanalys avseende Babesia equi |
Measurement of Theileria equi antibody (procedure) |
analys med direkt fluorescens avseende antikropp mot Bacillus anthracis |
Measurement of Bacillus anthracis antigen using direct fluorescence (procedure) |
antikroppsanalys med direkt fluorescens |
Direct tissue immunofluorescence procedure |
mekanisk komplikation av bröstprotes |
Mechanical complication of breast prosthesis |
mekanisk komplikation av cystostomikateter |
Mechanical complication of cystostomy catheter |
mekanisk komplikation av hjärtklaffprotes |
Mechanical complication of heart valve prosthesis |
mekanisk komplikation av intrauterint preventivmedel |
Mechanical complication of intrauterine contraceptive device |
mekanisk komplikation av intraokulärt linsimplantat |
Mechanical complication of intraocular lens |
Mechanical complication due to other implant or internal device, NOS |
Complication of surgical procedure |
mekanisk komplikation orsakad av protesrekonstruktion av sädesledare |
Mechanical complication of prosthetic reconstruction of vas deferens |
Mechanical complication of other specified device, implant or graft |
Complication of surgical procedure |
Mechanical complication of other vascular device, implant or graft |
Mechanical complication of cardiac device, implant AND/OR graft |
Mechanical strabismus from other musculofascial disorder |
Mechanical strabismus due to musculofascial disorder |
meklozin 12,5 mg, pastill |
Product containing precisely meclozine hydrochloride 12.5 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
biverkning av meklozinhydroklorid |
Adverse reaction to meclozine (disorder) |
MedDRA - SNOMED CT simple map reference set |
MedDRA to SNOMED CT simple map reference set (foundation metadata concept) |
Medial canthal ligament |
Structure of medial palpebral ligament |
Medical cardiovascular procedure |
Procedure on cardiovascular system |
Medical dermatologic procedure |
Procedure on integumentary system |
Medical procedure on heart |
Procedure on heart |
höjd läkemedelsdosering avböjd |
Medication dosage increase declined |
Medicinal gas |
Gaseous dose form |
medicinskt jod |
Iodine |
läkemedel med behandlingsfunktion mot gikt |
Uricosuric agent |
läkemedel med behandlingsfunktion som motgift |
Product containing antivenom (product) |
Medicinal product containing mercury and/or mercury compound and acting as diuretic agent (product) |
Mercurial diuretic agent |
Medroxyprogesterone 5mg / Conjugated Estrogens 625microgram tablet |
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) |
medroxiprogesteronacetat 104 mg, injektionsvätska, suspension, förfylld spruta 0,65 ml |
Medroxyprogesterone acetate 160 mg/mL suspension for injection |
Medullary carcinoma with amyloid stroma |
Medullary carcinoma with amyloid stroma |
medulloblastom |
Medulloblastoma |
Mefloquine hydrochloride 250mg tablet |
Product containing precisely mefloquine (as mefloquine hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) |
Megakaryoblast |
Megakaryoblast |
Megakaryocyte |
Megakaryocyte |
Megarectum |
Megacolon, not Hirschsprung's |
Meglumin iotroxinate |
Product containing iotroxic acid (medicinal product) |
megluminjotalamat 60 %, infusionsvätska, lösning, flaska |
Iothalamate only product |
melanocytnevus, kategori |
Pigmented nevus |
melanoma in situ, indelning efter lokalisation |
Melanoma in situ |
vaccin mot melanom |
Vaccine product |
melanomvaccin |
Vaccine product |
Melanoma: [skin] or [malignant] |
Malignant melanoma |
Melanoma: [skin] or [malignant] |
Malignant melanoma |
melanotisk neuroektodermal tumör hos barn |
Melanotic neuroectodermal tumor of infancy |
Melasian type |
Melasian type |
memantin 2 mg/ml, oral lösning |
Memantine hydrochloride 2 mg/mL oral solution |
Membrane metallo-endopeptidase |
Lymphocyte antigen CD10 |
Memory disturbance (& amnesia (& symptom)) |
Memory impairment (finding) |
Memory impairment |
Memory impairment (finding) |
meningeal tumör, oklart om benign eller malign |
Meningioma of uncertain behavior (morphologic abnormality) |
meningiom |
Benign meningioma |
biverkning av vaccin med meningokockpolysackarid |
Adverse reaction to meningococcal vaccine |
Menstrual molimen |
Premenstrual tension syndrome |
psykisk funktionsnedsättning |
Intellectual disability |
Mental handicap (specialty) |
Intellectual disability specialty |
psykisk funktionsnedsättning |
Intellectual disability specialty |
Mental handicap (specialty) |
Intellectual disability specialty |
avdelning för personer med psykisk funktionsnedsättning |
Intellectual disability psychiatry department (environment) |
psykiatrisk vård för personer med psykisk funktionsnedsättning |
Intellectual disability psychiatry service |
årlig fysisk undersökning av psykisk hälsa utförd |
Annual physical examination for people with mental illness completed |
vårdplan för krisreaktion |
Mental health crisis plan |
personlig hälsoplan för psykisk hälsa |
Mental health personal health plan |
mental retardation |
Intellectual disability |
screening för mental retardation |
Intellectual disability screening |
mentol 35,55 mg, inhalationskapsel |
Product containing only menthol in pulmonary dose form (medicinal product form) |
Mepacrine hydrochloride 100mg tablet |
Mepacrine hydrochloride 100 mg oral tablet |
petidinhydroklorid 100 mg/ml, injektionsvätska, lösning, ampull |
Product containing only pethidine in parenteral dose form (medicinal product form) |
petidinhydroklorid 50 mg/5 ml, sirap |
Pethidine hydrochloride 10 mg/mL oral solution |
petidinhydroklorid 50 mg/ml, injektionsvätska, lösning, ampull |
Product containing only pethidine in parenteral dose form (medicinal product form) |
petidinhydroklorid 50 mg + prometazinhydroklorid 50 mg, injektionsvätska, lösning, flaska |
Product containing only pethidine and promethazine (medicinal product) |
mepivakainhydroklorid 3 % + levonordefrin 1:20 000, injektionsvätska, lösning, flaska |
Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection |
mepivakainhydroklorid 30 mg + natriumklorid 3 mg, injektionsvätska, lösning, flaska |
Mepivacaine only product |
mepivakainhydroklorid 2 % + adrenalin 1:100 000, cylinderampull |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge |
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection |